Published in World J Transplant on December 24, 2013
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
Regulatory T cells in transplantation tolerance. Nat Rev Immunol (2003) 6.42
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood (2004) 6.02
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science (2002) 4.02
Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol (1998) 3.98
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med (2002) 3.97
Immune regulatory function of B cells. Annu Rev Immunol (2012) 3.55
Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol (1995) 3.17
Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr (2002) 2.70
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood (2004) 2.61
Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A (2001) 2.43
Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol (1996) 2.42
Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol (2012) 2.37
Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med (1997) 2.21
Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem (2002) 2.16
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol (1998) 1.96
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol (2012) 1.81
The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J Exp Med (2001) 1.80
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood (2008) 1.58
Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol (2004) 1.52
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol (2011) 1.45
The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol (1996) 1.38
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun (2005) 1.22
IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv Exp Med Biol (1999) 1.17
Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol (1999) 1.16
An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol (2005) 1.16
T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol (2003) 1.14
Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo. J Exp Med (1991) 1.13
Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med (1995) 1.11
Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant (2012) 1.10
Molecular aspects of regulatory T cell development. Semin Immunol (2004) 1.09
Multiple mechanisms of immune suppression by B lymphocytes. Mol Med (2012) 1.08
The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant (2010) 1.07
Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect. J Immunol (2004) 1.07
T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase. Infect Immun (1999) 1.07
Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell Microbiol (2010) 0.98
Generation and characterization of murine alternatively activated macrophages. Methods Mol Biol (2013) 0.96
Transplantation tolerance and cytokines: is suppressor cell activity mediated by Th2 cells? Folia Biol (Praha) (1998) 0.96
Cytokine gene expression in rejecting cardiac allografts. Transplantation (1992) 0.95
3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem Biophys Res Commun (2004) 0.95
Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect Immun (2002) 0.94
Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol (2001) 0.92
Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation (1998) 0.92
Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts. Transplantation (2002) 0.90
NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance. Transplantation (2000) 0.89
Essential role for B cells in transplantation tolerance. Curr Opin Immunol (2011) 0.89
The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation (1993) 0.88
Nitric oxide as a regulatory and effector molecule in the immune system. Mol Immunol (2002) 0.86
Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation (2002) 0.86
T-cell receptor specificity of CD8(+) Tregs in allotransplantation. Immunotherapy (2011) 0.82
Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism. Transplantation (2006) 0.82
Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice. Transpl Int (2002) 0.81
Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection. Mol Vis (2011) 0.81
Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages. Transpl Immunol (2009) 0.80
Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles. Transplantation (2005) 0.79
FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice. Nitric Oxide (2003) 0.78
Expression of nitric oxide and inducible nitric oxide synthase in acute renal allograft rejection in the rat. Int J Urol (2004) 0.78
The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells. Xenotransplantation (2005) 0.77
Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation (1993) 0.77
Graft survival and cytokine production profile after limbal transplantation in the experimental mouse model. Transpl Immunol (2010) 0.77
Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection. Transplantation (2003) 0.76
Clinical correlation of nitric oxide levels with acute rejection in renal transplantation. Int Urol Nephrol (2010) 0.76